Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69184bfede5d3e57a933eff1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glipizide Tablets ip 5mg",
"description": "GLIPIDIAB 5 is an oral antidiabetic medication containing Glipizide 5 mg, which belongs to the class of drugs known as sulfonylureas. It is widely prescribed for individuals with Type 2 Diabetes Mellitus (T2DM) to help control blood sugar levels when diet and lifestyle measures alone are not sufficient. GLIPIDIAB 5 works by stimulating the pancreas to produce more insulin and enhancing the body’s ability to utilize that insulin effectively.\n\nAs Type 2 diabetes often progresses over time, the pancreas gradually produces less insulin. GLIPIDIAB 5 helps bridge that gap by promoting insulin secretion, thereby lowering elevated fasting and post-meal blood glucose levels. It is usually taken once daily before meals, although dosage and frequency vary depending on a doctor’s evaluation of the patient’s condition.\n\nGLIPIDIAB 5 is often used alone or in combination with other antidiabetic medications such as metformin, DPP-4 inhibitors, or insulin, depending on the severity of blood sugar imbalance. Its predictable glucose-lowering effect makes it a long-standing and reliable treatment option in diabetes care.\n\nUses of GLIPIDIAB 5\n\nGLIPIDIAB 5 is primarily used for:\n\n1. Management of Type 2 Diabetes Mellitus\n\nIts main role is to help lower high blood glucose levels in adults diagnosed with T2DM. By improving insulin secretion, it helps maintain smoother and more stable sugar control throughout the day.\n\n2. Prevention of Diabetes-Related Complications\n\nMaintaining blood sugar within the target range reduces the risk of long-term complications such as:\n\nNerve damage (neuropathy)\n\nKidney disease (nephropathy)\n\nEye problems (retinopathy)\n\nCardiovascular diseases\n\nPoor wound healing\n\n3. Supporting Comprehensive Diabetes Treatment Plans\n\nGLIPIDIAB 5 is often part of a broader diabetes management plan that includes diet adjustment, physical activity, and regular monitoring of glucose levels.\n\nKey Benefits of GLIPIDIAB 5\n1. Effective Blood Sugar Reduction\n\nGLIPIDIAB 5 works quickly and efficiently to reduce blood sugar by boosting insulin release, making it effective for controlling both fasting and meal-related spikes in glucose.\n\n2. Long-Established Safety and Reliability\n\nGlipizide has been used in diabetes treatment for decades, with well-understood actions and predictable results. Its long history makes it a trusted choice among healthcare professionals.\n\n3. Convenient Once-Daily Dosing\n\nMost patients take the medicine once daily before breakfast, making it simple and easy to incorporate into a daily routine.\n\n4. Can Be Combined with Other Antidiabetic Medicines\n\nGLIPIDIAB 5 works well with other medications, especially when blood sugar control requires a multi-drug approach.\n\n5. Helps Reduce Future Health Risks\n\nBy maintaining controlled sugar levels, GLIPIDIAB 5 contributes to reducing the risk of serious long-term diabetes complications and enhances overall quality of life.\n\nPossible Side Effects\n\nLike all medications, GLIPIDIAB 5 may cause side effects. These vary among individuals and may include:\n\nCommon Side Effects\n\nLow blood sugar (hypoglycemia) — symptoms include sweating, dizziness, hunger, trembling, or palpitations\n\nNausea or stomach discomfort\n\nHeadache\n\nMild skin reactions such as rash or itching\n\nLess Common but Serious Side Effects\n\nSevere hypoglycemia, especially if meals are skipped or excessive insulin is produced\n\nLiver-related issues (rare)\n\nAllergic reactions such as swelling or severe skin redness\n\nBlood disorders like anemia (rare)\n\nTo reduce the risk of low blood sugar, regular meals and proper monitoring are important.\n\nConclusion\n\nGLIPIDIAB 5 is a proven and effective medication for managing Type 2 diabetes, particularly in patients who need additional insulin stimulation to maintain normal blood sugar levels. By enhancing natural insulin production and helping prevent long-term diabetes complications, it plays a vital role in comprehensive diabetes care. While it offers significant benefits, it must be used responsibly under medical supervision, especially because of its potential to cause low blood sugar. With consistent use, lifestyle adjustments, and regular monitoring, GLIPIDIAB 5 can greatly contribute to stable glucose control and improved overall health for individuals living with Type 2 diabetes.",
"price": 15.0,
"discountamount": 5.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2207,
"imageuri": "https://productimages.withfloats.com/actual/69184c00c1423dc102d9e723.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69184c00c1423dc102d9e723.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-15T09:46:38.169Z",
"updatedon": "2025-11-15T09:46:38.169Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glipizide-tablets-ip-5mg/2207",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Steris Healthcare Pvt Ltd",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6911af10f122e2a45d230b07",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 2 mg",
"description": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg is a triple-combination oral anti-diabetic medication formulated to achieve optimal blood sugar control in adults with Type 2 Diabetes Mellitus (T2DM). This unique blend brings together three complementary agents — Sitagliptin (a DPP-4 inhibitor), Metformin (a biguanide), and Glimepiride (a sulfonylurea) — that work through distinct mechanisms to enhance glucose regulation, improve insulin sensitivity, and support overall metabolic balance.\n\nThis advanced combination therapy is prescribed when monotherapy or dual therapy fails to achieve adequate glycemic control. It helps reduce both fasting plasma glucose (FPG) and postprandial glucose (PPG) levels, promoting stable long-term glycemic management.\n\nUses of Sitagliptin + Metformin + Glimepiride\n\nThis fixed-dose combination is primarily indicated for the management of Type 2 Diabetes Mellitus in adults. It is especially beneficial for patients whose blood sugar levels remain uncontrolled despite treatment with Metformin and Glimepiride or Metformin and Sitagliptin alone.\n\nIts main objectives include:\n\nControlling elevated blood glucose levels in adults with Type 2 diabetes\n\nReducing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases\n\nSupporting better insulin utilization by the body\n\nComplementing diet, exercise, and lifestyle modification to maintain optimal glycemic balance\n\nMechanism of Action\n\nEach component of this combination plays a vital role in maintaining blood sugar control:\n\nSitagliptin (50 mg) – A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin release and suppress glucagon production when blood glucose levels rise, thereby improving post-meal glucose control.\n\nMetformin Hydrochloride (1000 mg) – A biguanide that lowers glucose production in the liver and increases the body’s sensitivity to insulin. It also decreases intestinal glucose absorption, making it an essential first-line therapy in diabetes management.\n\nGlimepiride (2 mg) – A sulfonylurea that stimulates pancreatic beta cells to release more insulin, especially when blood glucose levels are high. It works synergistically with Metformin and Sitagliptin for more effective glycemic control.\n\nKey Benefits\n\nTriple Mechanism for Superior Control:\nBy combining three potent agents, the medication addresses multiple pathways of glucose regulation—insulin secretion, insulin sensitivity, and hepatic glucose output—resulting in comprehensive and consistent control of blood sugar levels.\n\nEffective Glycemic Stability:\nThe combination helps maintain target HbA1c levels and reduces both fasting and post-meal glucose spikes without significant weight gain when used with proper diet and exercise.\n\nReduced Risk of Diabetic Complications:\nLong-term blood sugar control minimizes the risk of complications such as kidney disease, vision problems, nerve damage, and heart conditions associated with uncontrolled diabetes.\n\nConvenient Fixed-Dose Formulation:\nCombining three medications into a single tablet simplifies dosing schedules, improves patient adherence, and reduces pill burden, which is crucial for long-term treatment success.\n\nImproved Insulin Efficiency:\nEnhances the body's natural insulin response and glucose metabolism, allowing for smoother daily energy levels and reduced fatigue associated with hyperglycemia.\n\nPossible Side Effects\n\nWhile this combination is generally well tolerated, some patients may experience side effects, especially at the beginning of therapy. Common and rare side effects include:\n\nHypoglycemia (low blood sugar): More likely when meals are skipped or during excessive physical exertion. Symptoms include sweating, dizziness, and rapid heartbeat.\n\nGastrointestinal disturbances: Such as nausea, vomiting, diarrhea, abdominal discomfort, or loss of appetite (mostly due to Metformin).\n\nHeadache or Weakness: Usually mild and transient.\n\nAllergic reactions: Rarely, rash or itching may occur.\n\nLactic Acidosis (rare but serious): A potential complication of Metformin, particularly in patients with kidney impairment or excessive alcohol consumption.\n\nWeight gain: Mild weight gain may occur due to Glimepiride’s insulin-enhancing effect.\n\nPrecautions:\n\nRegular monitoring of blood sugar levels and kidney function is essential.\n\nAvoid alcohol and consult a doctor before using this medicine if you have liver or kidney disease.\n\nThe medication should not be used in patients with Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nThe combination of Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg represents a powerful and balanced therapy for adults with Type 2 Diabetes Mellitus, especially those requiring triple-drug intervention to achieve desired glycemic control. Its multi-targeted approach ensures effective management of both fasting and postprandial glucose levels, thereby improving long-term metabolic health and reducing the risk of complications.",
"price": 295.0,
"discountamount": 89.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2197,
"imageuri": "https://productimages.withfloats.com/actual/6911af137e4c90e1dc453884.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6911af137e4c90e1dc453884.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-10T09:23:28.795Z",
"updatedon": "2025-11-10T09:27:11.643Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-2-mg/2197",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN GM 50+1000+2 ",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68e7a474f3481c1f16d3b038",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)",
"description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.",
"price": 180.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2185,
"imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-10-09T12:03:00.012Z",
"updatedon": "2025-10-09T12:03:00.012Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN GM",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "68b0256b813270ffac595cb0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 100",
"description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.",
"price": 550.0,
"discountamount": 165.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2166,
"imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:46:19.602Z",
"updatedon": "2025-08-28T09:46:19.602Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 100 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "68b02393f5434d48fca8b8ca",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 50",
"description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.",
"price": 375.0,
"discountamount": 112.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2165,
"imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:38:27.036Z",
"updatedon": "2025-08-28T09:38:27.036Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 50 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "681c5e9e5a26e4010ea42029",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ST-GLIPTIN M 100/ 1000",
"description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.",
"price": 225.0,
"discountamount": 68.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"1001000 works",
"100 1000stgliptin",
"work stgliptin",
"balanced diet",
"tablet maintain",
"diabetic individuals",
"sitagliptin 100 mg",
"timely intervention",
"rash itching",
"medical attention",
"highdose metforminseek",
"assess effectiveness",
"active lifestyle",
"pancreas produce",
"synergistic mechanism",
"antidiabetic therapies",
"hypoglycemia compared",
"glycemic control",
"biguanide class",
"incretin hormones",
"respond adequately",
"powerful combination",
"insulin facilitating",
"sugar produced",
"side effect",
"bodys sensitivity",
"effective management",
"blood sugar",
"increases insulin sensitivity",
"regulate blood sugar",
"glucose metabolism directions",
"increasing insulin release",
"bothersome side effects",
"diabetes management minimizes",
"optimize absorption swallow",
"slight weight loss",
"support weight neutrality"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2107,
"imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T07:34:54.516Z",
"updatedon": "2025-05-08T07:35:36.782Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/st-gliptin-m-100-1000/2107",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "sitagliptin and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin and Metformin hydrochloride tablets Uses in Hindi",
"sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi",
"sitagliptin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "674b0a7ee34075b8291b14f1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride 0.5 mg, Voglibose 0.2 mg & Metformin Hydrochloride (SR) 500 mg Tablets",
"description": "Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.\n\n \nKey Benefits:\nEffective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.\nReduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.\nMinimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.\nImproves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.\nSustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.\nComprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.\nHow Does It Work?\nGlimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.\nVoglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.\nMetformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.\nTogether, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.\n\nDirections for Use:\nDosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.\nSwallow Whole: Do not crush or chew the tablet; it is designed for sustained release.\nTiming: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.\nFollow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.\nAlways consult your doctor before starting or adjusting your dosage.\n\nSide Effects:\nWhile Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nStomach discomfort or flatulence\nMild hypoglycemia (low blood sugar levels)\nRare but Serious Side Effects:\n\nSevere hypoglycemia\nLactic acidosis (from Metformin)\nAllergic reactions such as rash or itching\n\n",
"price": 153.0,
"discountamount": 46.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"prescribed dosage",
"ingredients address",
"glycemic control",
"targets fasting",
"generally welltolerated",
"glimiteris trio 0502500",
"optimal results",
"meals swallow",
"healthcare professional",
"holistic solution",
"multifaceted nature",
"cardiovascular issues",
"neuropathy retinopathy",
"insulin improving",
"bodys response",
"multiple pathways",
"synergistic combination",
"multifaceted approach",
"dosage side effects",
"delaying glucose absorption",
"postprandial blood glucose",
"metformin allergic reactions",
"diarrhea stomach discomfort",
"experience side effects",
"reduce gastrointestinal discomfort",
"work glimepiride stimulates",
"proven antidiabetic agents"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2016,
"imageuri": "https://productimages.withfloats.com/actual/674b0a80ec7bb8b7dcae8a8a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/674b0a80ec7bb8b7dcae8a8a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-11-30T12:52:14.799Z",
"updatedon": "2024-11-30T12:52:14.799Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-0-5-mg-voglibose-0-2-mg-metformin-hydrochloride-sr-500-mg-tablets/2016",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIMITERIS TRIO 0.5/0.2/500 ",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662cd3e870e7b20c49e689e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VOGLIGOLD G3 M0.3 ",
"description": "VOGLIGOLD G3 M0.3 \nVoglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg\nIntroduction to VOGLIGOLD G3 M0.3\nVOGLIGOLD G3 M0.3 is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains three active ingredients: Voglibose 0.3mg, Glimepiride 3mg, and Metformin Hydrochloride 500mg. This multi-action formula targets different aspects of glucose regulation to provide comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nVoglibose 0.3mg\nVoglibose is an alpha-glucosidase inhibitor that works by:\n\nSlowing Carbohydrate Absorption: Voglibose inhibits the alpha-glucosidase enzyme in the small intestine, delaying the breakdown of complex carbohydrates into glucose. This helps to smooth out postprandial (after-meal) blood glucose peaks.\nGlimepiride 3mg\nGlimepiride is a sulfonylurea that helps control blood sugar by:\n\nStimulating Insulin Secretion: Glimepiride stimulates the pancreas to release more insulin, which helps lower blood sugar levels, particularly after meals.\nMetformin Hydrochloride 500mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReducing Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproving Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreasing Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nBenefits of VOGLIGOLD G3 M0.3\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Voglibose, Glimepiride, and Metformin effectively manages both fasting and postprandial blood sugar levels.\nEnhanced Insulin Secretion and Sensitivity: Glimepiride enhances insulin secretion, while Metformin improves insulin sensitivity, and Voglibose slows carbohydrate absorption.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: The risk of hypoglycemia is minimized due to the complementary actions of the three components.\nWeight Neutrality: Metformin and Voglibose are generally weight neutral, making this combination favorable for patients concerned about weight gain associated with diabetes medications.\nHow to Use VOGLIGOLD G3 M0.3\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, as prescribed by your healthcare provider.\nAdministration: Take the tablet with meals to reduce gastrointestinal side effects and enhance the absorption of Metformin. Swallow the tablet whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VOGLIGOLD G3 M0.3 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vogligold-g3-m0-3-134319",
"price": 185.0,
"discountamount": 55.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"meal",
"diet",
"Order",
"glass",
"water",
"EMAIL",
"liver",
"adults",
"amount",
"Fasting",
"readings",
"patients",
"pancreas",
"Low Risk",
"exercise",
"breakdown",
"same time",
"biguanide",
"Decreasing",
"one tablet",
"Guidelines",
"Glimepiride",
"Adjustments",
"weight gain",
"information",
"utilization",
"Optimal Use",
"best results",
"Introduction",
"sterispharma",
"sulfonylurea",
"Hypoglycemia",
"muscle cells",
"sterisonline",
"CALL/WHATSAPP",
"Voglibose 0.3",
"Administration",
"typical dosage",
"glucose uptake",
"treatment plan",
"Consistent Use",
"Key Components",
"small intestine",
"glycemic control",
"three components",
"VOGLIGOLD G3 M0.3",
"different aspects",
"Weight Neutrality",
"several mechanisms",
"glucose regulation",
"Regular monitoring",
"Recommended Dosage",
"blood glucose peaks",
"Insulin Sensitivity",
"healthcare provider",
"diabetes medications",
"effective management",
"multi-action formula",
"complex carbohydrates",
"Intestinal Absorption",
"complementary actions",
"gastrointestinal tract",
"combination medication",
"Metformin Hydrochloride",
"Carbohydrate Absorption",
"alpha-glucosidase enzyme",
"three active ingredients",
"type 2 diabetes mellitus",
"Enhanced Insulin Secretion",
"Additional Health Benefits",
"Hepatic Glucose Production",
"alpha-glucosidase inhibitor",
"gastrointestinal side effects",
"Postprandial Glucose Management",
"postprandial blood sugar levels",
"comprehensive blood sugar control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1519,
"imageuri": "https://productimages.withfloats.com/actual/667d30b6c303c6d6ad136ea4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d30b6c303c6d6ad136ea4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T09:05:02.904Z",
"updatedon": "2024-06-27T09:28:16.215Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vogligold-g3-m0-3-/1519",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VOGLIGOLD G3 M0.3 ",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride 3mg+metformin 500mg+voglibose 0.3 mg",
"voglibose glimepiride + metformin hydrochloride us",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662c81c7247ae19c482b3d9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE 100 ",
"description": "VILDIABATE 100 \nVildagliptin (100mg)\nIntroduction to VILDIABATE 100\nVILDIABATE 100 is an oral medication designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin helps regulate blood sugar levels by enhancing the body’s natural ability to produce insulin and control glucose production. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVildagliptin 100mg\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These incretin hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin secretion in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 100\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 100\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 100 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452",
"price": 275.0,
"discountamount": 82.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"diet",
"body",
"EMAIL",
"Order",
"meals",
"water",
"glass",
"GLP-1",
"liver",
"adults",
"Action",
"amount",
"option",
"potent",
"readings",
"Low Risk",
"appetite",
"exercise",
"patients",
"same time",
"Mechanism",
"regulation",
"VILDIABATE",
"one tablet",
"Guidelines",
"management",
"food intake",
"weight gain",
"Optimal Use",
"information",
"conjunction",
"Adjustments",
"Introduction",
"Vildagliptin",
"sterisonline",
"best results",
"crucial role",
"DPP-4 enzyme",
"Hypoglycemia",
"instructions",
"sterispharma",
"Key Component",
"CALL/WHATSAPP",
"typical dosage",
"Consistent Use",
"Administration",
"treatment plan",
"Weight Neutral",
"natural ability",
"oral medication",
"low blood sugar",
"glucagon release",
"DPP-4) inhibitor",
"natural response",
"glycemic control",
"individual needs",
"gastric emptying",
"insulin secretion",
"incretin hormones",
"glucose metabolism",
"Recommended Dosage",
"Regular monitoring",
"healthcare provider",
"blood glucose levels",
"pancreatic beta cells",
"dipeptidyl peptidase-4",
"Fasting Glucose Control",
"meal) blood sugar levels",
"type 2 diabetes mellitus",
"glucose-dependent manner",
"selective DPP-4 inhibitor",
"Additional Health Benefits",
"hepatic glucose production",
"other diabetes medications",
"Postprandial Glucose Control",
"Effective Blood Sugar Control",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1514,
"imageuri": "https://productimages.withfloats.com/actual/667d3bc9c134db5b38ba8354.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d3bc9c134db5b38ba8354.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T08:43:08.09Z",
"updatedon": "2024-06-27T10:15:31.785Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1514",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE 100 ",
"category": "DIABETIC RANGE",
"tags": [
"vildagliptin 100 mg uses",
"",
"vildagliptin 100 mg generic medicine",
"vildagliptin 100 mg side effects",
"",
"vildagliptin sustained release tablets 100 mg",
"vildagliptin 100 mg brands in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}